Part 4 – Mortality and life expectancy in IBD patients

Czech version

Authors: Dušek L. ^1,2; Májek O. ²; Jarkovský J. ^1,2; Benešová K. ^1,2; Ngo O. ²; Mužík J. ²; Kubát J. ¹; Blaha M. ¹; Hejduk K. ²; Lukáš M. ³
Authors‘ workplace: Ústav zdravotnických informací a statistiky ČR, Praha ¹; Institut biostatistiky a analýz, LF MU, Brno ²; Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F. a. s. a 1. LF UK, Praha ³
Published in: Gastroent Hepatol 2019; 73(4): 345-351
Category:

Sources

1. Eurostat Statistics Explained. Amenable and preventable deaths statistics. 2018. [online]. Available from: https: //ec.europa.eu/eurostat/statistics-explained/index.php?title=Archive: Amenable_and_preventable_deaths_statistics.

2. Chiang CL. The life table and its applications. Malabar: Robert E Krieger Publishing Company 1984.

3. Keyfitz N, Caswell H. Applied mathematical demography. New York: Springer-Verlag 2005.

4. Preston S, Heuveline P, Guillot M. Demography: measuring and modeling population processes. Blackwell 2001.

Labels

Paediatric gastroenterology Gastroenterology and hepatology Surgery

Clinical and experimental gastroenterology

Evolution of insulin resistance after liver transplantation – a prospective study

The role of pH impedance in patients with excessive supragastric belching

Imaging activity in nerves that mediate pain from gastrointestinal organs

Does proton pump inhibitors treatment affect the risk of gastrointestinal bleeding in patients on novel antithrombotic therapy?

New oral anticoagulants and upper gastrointestinal bleeding

Insulinoma as a cause of severe hypoglycemia in a patient with neurological symptoms

Dysphagia as a symptom of an adverse effect of anticoagulant therapy

Unusual manifestation of tuberculosis in an ulcerative colitis patient treated with infliximab

Memory B lymphocytes in peripheral blood in coeliac disease – a pilot study

Cystic fibrosis and exocrine pancreatic insufficiency

Dvě dekády endoskopické léčby časného karcinomu žaludku v České republice perspektivou kongresu IGCC 2019

Tofacitinib – the fi rst JAK inhibitor in the treatment of ulcerative colitis. Beginning of the therapeutic era of „small molecules“ in infl ammatory bowel disease?

Article was published in

Gastroenterology and Hepatology

2019 Issue 4